Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

FDA Rejects More China Drugs; Clue to Uterine Ca Disparity; Cancer-Vax Controversy,

A phase I/II trial of sitravatinib and nivolumab (Opdivo) for previously … and enrollment in clinical trials involving the radioligand products, …, A phase I/II trial of sitravatinib and nivolumab (Opdivo) for previously … and enrollment in clinical trials involving the radioligand products, …, Read More

Scroll to Top